Page 71 - L&H_ed 242_digital

ARTIGO CIENTÍFICO TERAPIA CELULAR

8. DIB, N. et al. One-year follow-up of f 25. HERREROS, J. et al. Autologous intramyocardial with chronic heart failure after myocardial
easibility and safety of the first U.S., randomized, injection of cultured skeletal muscle-derived infarction. Am Heart J, 2011;162:654-662.
controlled study using 3-dimensional stem cells in patients with non-acute myocardial
guided catheter-based delivery of autologous infarction. Eur Heart J, 2003;24:2012–2020. 42. PTASZEK, L. M. et al. Towards regenerative
skeletal myoblasts for ischemic cardiomyopathy therapy for cardiac disease. Lancet, 2012, 379,
(CAuSMIC study). JACC Cardiovasc Interv, 26. HONG, S. J. et al. Intravenous xenogeneic 933–942.
2009;2:9–16. transplantation of human adipose-derived stem 43. REINECKE, H. et al. Electromechanical
cells improves left ventricular function and
9. DIB, N. et al. Safety and feasibility of autologous microvascular integrity in swine myocardial coupling between skeletal and cardiac muscle.
Implications for infarct repair. J Cell Biol.,
myoblast transplantation in patients with infarction model. Catheter Cardiovasc Interv, 2000;149(3):731-40.
ischemic cardiomyopathy: four-year follow-up. 2015;86:E38-E48.
Circulation, 2005;112:1748–1755. 44. REINECKE, H.; POPPA, V.; MURRY, C. E. Skeletal
27. INCE, H. et al. Transcatheter transplantation of
10. DIXIT, P.; KATARE, R. Challenges in identifying the autologous skeletal myoblasts in pos tinfarction muscle stem cells do not transdifferentiate into
cardiomyocytes after cardiac grafting. J Mol Cell
best source of stem cells for cardiac regeneration patients with severe left ventricular dysfunction. Cardiol., 2002;34(2):241-9.
therapy. Stem Cell Res. Ther., 2015, 6, 26. J Endovasc Ther, 2004;11:695–704.
45. SCHENKE-LAYLAND, K. et al. Adipose tissue-
11. DOWELL, J. D. et al. Myocyte and myogenic stem 28 JI, S.T. et al. Promising therapeutic strategies for derived cells improve cardiac function following
cell transplantation in the heart. Cardiovasc Res., mesenchymal stem cell-based cardiovascular myocardial infarction. J Surg Res, 2009;153:217–223.
2003;58(2):336-50. regeneration: From cell priming to tissue
engineering. Stem Cells Int., 2017, 3945403. 46. SEROPIAN, I. M. et al. Anti-inflammatory
12. DUCKERS, H. J. et al. Final results of a phase strategies for ventricular remodeling following
IIa, randomised, open-label trial to evaluate the 29. KIM, J. H. et al. Transplantation of Adipose- ST-segment elevation acute myocardial
percutaneous intramyocardial transplantation Derived Stem Cell Sheet Attenuates Adverse infarction. J. Am. Coll. Cardiol., 2014, 63,
of autologous skeletal myoblasts in congestive Cardiac Remodeling in Acute Myocardial 1593–1603.
heart failure patients: the SEISMIC trial. Infarction. Tissue Eng Part A, 2017;23:1–11.
EuroIntervention, 2011;6:805–812. 47. SIMINIAK, T. et al. Percutaneous trans-coronary-
30. LAROSE, E. et al. Percutaneous versus surgical venous transplantation of autologous skeletal
13. DURRANI, S. et al. Skeletal myoblasts for cardiac delivery of autologous myoblasts after chronic myoblasts in the treatment of post-infarction
repair. Regen Med, 2010;5:919–932. myocardial infarction: an in vivo cardiovascular myocardial contractility impairment: the
magnetic resonance study. Catheter Cardiovasc
14. FAIELLA,W.; ATOUI, R. Therapeutic use of stem Interv., 2010;75(1):120-7. POZNAN trial. Eur Heart J, 2005;26:1188–1195.
cells for cardiovascular disease. Clin. Trans. Med., 48. SIMINIAK, T. et al. Autologous skeletal myoblast
2016, 5, 34. 31. LEOBON, B. et al. Myoblasts transplanted into transplantation for the treatment of post
rat infracted myocardium are functionally
15. FARAHMAND P, et al. Skeletal myoblasts isolated from their host. Proc Natl Acad Sci U S A, infarction myocardial injury: phase I clinical
preserve remote matrix architecture and global 2003;100:7808–7411. study with 12 months of follow-up. Am Heart J,
function when implanted early or late after 2004;148:531–537.
coronary ligation into infracted or remote 32. MA, T. et al. A brief review: Adipose-derived 49. SMITS, P. C. et al. Catheter-based intramyocardial
myocardium. Circulation, 2008;118:S130-1307. stem cells and their therapeutic potential in injection of autologous skeletal myoblasts as
cardiovascular diseases. Stem Cell Res. Ther., a primary treatment of ischemic heart failure:
16. FERNANDES, S. et al. Autologous myoblast 2017, 8, 124.
transplantation after myocardial infarction clinical experience with six-month follow-up. J
increases the inducibility of ventricular 33. MAURO, A. Satellite cell of skeletal muscle fibers. Am Coll Cardiol, 2003;42:2063–2069.
arrhythmias. Cardiovasc Res., 2006;69(2):348-58. J Biophys Biochem Cytol. 1961;9:493-5. 50. SOUZA, C. F.; ALVES, C. M. R.; CARVALHO, A. C. C.
17. FINEGOLD, J. A.; ASARIA, P.; FRANCIS, D. P. 34. MAZO, M. et al. Treatment of reperfused Skeletal Myoblast: fair abandonment? Rev Bras
Mortality from ischaemic heart disease by ischemia with adipose-derived stem cells in a Cardiol., 2011;24(2):105-111.
country, region, and age: Statistics from World preclinical Swine model of myocardial infarction. 51. SUZUKI, K. et al. Overexpression of connexin-43
Health Organization and United Nations. Int. J. Cell Transplant, 2012;21:2723–2733. in skeletal myoblasts: relevance to cell
Cardiol., 2013, 168, 934–945. transplantation to the heart. J Thorac Cardiovasc
35. MCCONNELL, P. I. et al. Correlation of autologous
18. FUKUSHIMA, S. et al. Choice of cell-delivery skeletal myoblast survival with changes in left Surg., 2001;122(4):759-66.
route for skeletal myoblast transplantation for ventricular remodeling in dilated ischemic heart 52. SUZUKI, K. et al. Intracoronary infusion of
treating post-infarction chronic heart failure in failure. [Abstract]. J Thorac Cardiovasc Surg., skeletal myoblasts improves cardiac function in
rat. PLoS One, 2008;3:e3071. 2005;130(4):1001. doxorubicin-induced heart failure. Circulation
19. GAVIRA, J. J. et al. Autologous skeletal myoblast 36. MENASCHE, P. et al. The Myoblast Autologous 2001;104:I213-217.
transplantation in patients with nonacute Grafting in Ischemic Cardiomyopathy (MAGIC) 53. VALINA, C. et al. Intracoronary administration
myocardial infarction: 1-year follow-up. J Thorac trial: first randomized placebo-controlled of autologous adipose tissue-derived stem cells
Cardiovasc Surg, 2006;131:799–804. study of myoblast transplantation. Circulation, improves left ventricular function, perfusion, and
2008;117:1189–1200. remodelling after acute myocardial infarction.
20. GAVIRA, J. J. et al. Repeated implantation Eur Heart J, 2007;28:2667–2677.
of skeletal myoblast in a swine model of 37. MENASCHE, P. et al. Autologous skeletal
chronic myocardial infarction. Eur Heart J., myoblast transplantation for severe post 54. VAN DEN BOS, E. J. et al. Functional assessment
2010;31(8):1013-21. infarction left ventricular dysfunction. J Am Coll of myoblast transplantation for cardiac repair
Cardiol, 2003;41:1078–1083. with magnetic resonance imaging. Eur J Heart
21. GAVIRA, J. J. et al. A comparison between
percutaneous and surgical transplantation of 38. MURTUZA, B. et al. Transplantation of Fail, 2005;7(4):435-43.
autologous skeletal myoblasts in a swine model skeletal myoblasts secreting an IL-1 inhibitor 55. VELTMAN, C. E. et al. Four-year follow-up
of chronic myocardial infarction. Cardiovasc modulates adverse remodeling in infarcted of treatment with intramyocardial skeletal
Res., 2006;71(4):744-53. murine myocardium. Proc Natl Acad Sci U S A., myoblasts injection in patients with ischaemic
2004;101(12):4216-21. cardiomyopathy. Eur Heart J, 2008;29:1386–1396.
22. GHOSTINE, S. et al. Long-term efficacy of
myoblast transplantation on regional structure 39. ORLIC, D.; HILL, J.; ARAI, A. Stem Cells for Myocardial 56. VERHEULE, S. et al. Characterization of gap
and function after myocardial infarction. Regeneration. Circ Res., 2002, 13, 1092–1102. junction channels in adult rabbit atrial and
Circulation, 2002;106(12 Suppl 1): I131-6. ventricular myocardium. Circ Res,1997;80(5):673-81.
40. PAYNE, T. et al. A relationship between vascular
23. HAGEGE, A. A. et al. Skeletal myoblast endothelial growth factor, angiogenesis, 57. YIN, H.; PRICE, F.; RUDNICKI, M. A. Satellite
transplantation in ischemic heart failure: and cardiac repair after muscle stem cell cells and the muscle stem cell niche. Physiol
long-term follow-up of the first phase I cohort of transplantation into ischemic hearts. J Am Coll Rev,2013;93:23–67.
patients. Circulation, 2006;114:I108-113. Cardiol, 2007;50(17):1677-84.
58. YU, L. H. et al. Improvement of cardiac function
24. HE, K. L. et al. Autologous skeletal myoblast 41. POVSIC, T. J. et al. A double-blind, randomized, and remodeling by transplanting adipose
transplantation improved hemodynamics and controlled, multicenter study to assess the safety tissue-derived stromal cells into a mouse model
left ventricular function in chronic heart failure and cardiovascular effects of skeletal myoblast of acute myocardial infarction. Int J Cardiol,
dogs. J Heart Lung Transplant., 2005;24(11):1940-9. implantation by catheter delivery in patients 2010;139:166–172.
70